From: Long-term follow-up after laparoscopic management of endometrial cancer: a 15-year cohort study
Mean operative time | 173.2 min (70–300) | Intraoperative complications | 11 (5.6%) | |
(TLH + pelvic lymphadenectomy) | Â | Â | Â | Â |
Conversion rate | 9 (4.3%) | Haemorrhage | 1 | Controlled vaginally |
Mean hospital stay (days) | 5 (2–16) | Bladder injury | 1 | Treated laparoscopically during operation |
Mean return bowel activity (days) | 1.4 (1–3) | Subcutaneous emphysema | 5 | One case required late conversion to perform lymphadenectomy |
Recurrence rate | 21 (10.6%) | Gas embolism | 1 | Operative time 70 min. Favourable outcome |
Para-aortic lymphadenectomy | 3 (1.5%) | Blood transfusion | 3 | Â |
Mean no. of pelvic nodes | 10 (2–25) | Postoperative complications |  | 13 (6.6%) |
Lymphadenectomies indicated and not performed | 20 (12.9%) | Hemoperitoneum | 1 | Required laparotomy and blood transfusion 48 h after surgery |
Positive cytology | 15 (7.6%) | Pulmonary embolism | 1 | Discharged in good conditions |
Upstaged patients | 23 (11.6%) | Vesicovaginal fistula | 1 | 3 months after surgery. Managed laparoscopically |
Cause-specific survival | 93.2% | Intestinal sub-oclussion | 1 | Requiring readmission and medical treatment 3 weeks after surgery |
Median recurrence-free interval | 35 months | Phlebitis | 2 | Â |
Mean follow-up | 74.8 months | Port site hernia | 1 | Â |
Overall survival | 88.9% | Obturator neuropathy | 3 | Resolved spontaneously. |
Disease-free survival | 89.3% | Lymphedema/Lymphocyst | 2 | Resolved spontaneously. |
Adjuvant therapy | 156 (78.8%) | Vaginal cuff dehiscence | 1 | Previous radiotherapy. Cuff dehiscence 6 years after surgery. Re-closure without complications |